Every open market buy and sale of Taysha Gene Therapies, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $6.7M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when TSHA insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an TSHA officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every TSHA insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | Sukumar NagendranPresident and Head of R&D | Sale plan | 200,000 | $6.24 | $1.2M | 936,410 | Jul 10Form 4 |
| Apr 10, 2026 | Sukumar NagendranPresident and Head of R&D | Sale plan | 200,000 | $4.46 | $892K | 1,136,410 | Apr 13Form 4 |
| Feb 4, 2026 | Kamran AlamCFO | Sale | 1,655 | $4.52 | $7K | 1,442,131 | Feb 6Form 4 |
| Jan 26, 2026 | Sean P. NolanCEO | Sale | 178,101 | $4.72 | $840K | 2,908,257 | Jan 27Form 4 |
| Jan 26, 2026 | Sukumar NagendranPresident and Head of R&D | Sale | 116,050 | $4.72 | $547K | 1,317,389 | Jan 27Form 4 |
| Jan 26, 2026 | Kamran AlamCFO | Sale | 102,817 | $4.72 | $485K | 1,443,786 | Jan 27Form 4 |
| Jan 12, 2026 | Sukumar NagendranPresident and Head of R&D | Sale plan | 200,000 | $4.71 | $942K | 1,006,439 | Jan 14Form 4 |
| Dec 1, 2025 | Sukumar NagendranPresident and Head of R&D | Sale | 370,172 | $4.58 | $1.7M | 1,006,439 | Dec 1Form 4 |
| Sep 10, 2025 | Sukumar NagendranPresident and Head of R&D | Sale plan | 200,000 | $3.23 | $646K | 1,006,439 | Sep 12Form 4 |
| Aug 21, 2025 | Kamran AlamCFO | Sale | 54,491 | $2.85 | $155K | 1,187,603 | Aug 22Form 4 |
| Aug 21, 2025 | Sukumar NagendranPresident and Head of R&D | Sale | 57,054 | $2.85 | $163K | 1,165,289 | Aug 22Form 4 |
| May 30, 2025 | Paul B Manning10% owner | Buy | 750,000 | $2.75 | $2.1M | 2,841,704 | Jun 3Form 4 |
TSHA insider trading FAQ
Are TSHA insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of TSHA on the open market in 0 trades, and 3 sold $6.7M in 8 trades, 46% of that under pre-arranged trading plans.
When did an TSHA insider last buy shares?
Paul B Manning (10% owner) bought 750,000 shares for $2.1M on May 30, 2025, reported on Jun 3, 2025.
When did an TSHA insider last sell shares?
Sukumar Nagendran (President and Head of R&D) sold 200,000 shares for $1.2M on Jul 10, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
